Cargando…
Screening test for neutralizing antibodies against yellow fever virus, based on a flavivirus pseudotype
Given the possibility of yellow fever virus reintroduction in epidemiologically receptive geographic areas, the risk of vaccine supply disruption is a serious issue. New strategies to reduce the doses of injected vaccines should be evaluated very carefully in terms of immunogenicity. The plaque redu...
Autores principales: | Mercier-Delarue, Séverine, Durier, Christine, Colin de Verdière, Nathalie, Poveda, Jean-Dominique, Meiffrédy, Vincent, Fernandez Garcia, Maria Dolores, Lastère, Stéphane, Césaire, Raymond, Manuggera, Jean-Claude, Molina, Jean-Michel, Amara, Ali, Simon, François |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5451040/ https://www.ncbi.nlm.nih.gov/pubmed/28562615 http://dx.doi.org/10.1371/journal.pone.0177882 |
Ejemplares similares
-
Hepatitis Rebound after Infection with Yellow Fever Virus
por: Denis, Blandine, et al.
Publicado: (2019) -
Detection of Extensive Cross-Neutralization between Pandemic and Seasonal A/H1N1 Influenza Viruses Using a Pseudotype Neutralization Assay
por: Labrosse, Béatrice, et al.
Publicado: (2010) -
Novel synthetic nucleotides of notifiable dengue (1–4), Japanese encephalitis, yellow fever and Zika flaviviruses
por: Camer, Gerry Amor, et al.
Publicado: (2018) -
Longitudinally Profiling Neutralizing Antibody Response to SARS Coronavirus with Pseudotypes
por: Temperton, Nigel J., et al.
Publicado: (2005) -
Pseudotype-Based Neutralization Assays for Influenza: A Systematic Analysis
por: Carnell, George William, et al.
Publicado: (2015)